Smith & Nephew plc (LON:SN) Given Average Recommendation of “Hold” by Analysts
Shares of Smith & Nephew plc (LON:SN) have been assigned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is GBX 1,771.14 ($23.14).
SN has been the subject of a number of analyst reports. Citigroup reduced their price target on Smith & Nephew from GBX 1,700 ($22.21) to GBX 1,670 ($21.82) and set a “neutral” rating for the company in a research report on Thursday, June 18th. Morgan Stanley reduced their price target on Smith & Nephew from GBX 1,950 ($25.48) to GBX 1,940 ($25.35) and set an “overweight” rating for the company in a research report on Thursday, July 30th. JPMorgan Chase & Co. reduced their price target on Smith & Nephew from GBX 1,633 ($21.34) to GBX 1,553 ($20.29) and set a “neutral” rating for the company in a research report on Thursday, July 30th. Credit Suisse Group dropped their price objective on Smith & Nephew from GBX 1,685 ($22.02) to GBX 1,675 ($21.89) and set a “neutral” rating on the stock in a research note on Thursday, July 30th. Finally, Shore Capital reiterated a “sell” rating on shares of Smith & Nephew in a research note on Wednesday, July 29th.
In other news, insider Virginia Bottomley purchased 258 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were purchased at an average cost of GBX 1,515 ($19.80) per share, for a total transaction of £3,908.70 ($5,107.41).
The company also recently declared a dividend, which will be paid on Wednesday, October 28th. Investors of record on Thursday, October 1st will be paid a dividend of $0.14 per share. The ex-dividend date is Thursday, October 1st. This represents a yield of 0.68%. Smith & Nephew’s dividend payout ratio is 67.26%.
About Smith & Nephew
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Story: Why are percentage gainers important?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.